DrugPatentWatch Database Preview
Details for Patent: 9,669,009
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 9,669,009 protect, and when does it expire?
Patent 9,669,009 protects SPRITAM and is included in one NDA.
This patent has seventeen patent family members in nine countries.
Summary for Patent: 9,669,009
Title: | Rapid disperse dosage form containing levetiracetam |
Abstract: | A high dose rapidly dispersing three-dimensionally printed dosage form comprising a high dose of levetiracetam in a porous matrix that disperses in water within a period of less than about 15 seconds is disclosed. Also disclosed are methods of preparing the dosage form and of treating a condition, disease or disorder that is therapeutically responsive to levetiracetam. |
Inventor(s): | Jacob; Jules (Yardley, PA), Coyle; Norman (Fort Washington, PA), West; Thomas G. (Lawrenceville, NJ), Monkhouse; Donald C. (Radnor, PA), Surprenant; Henry L. (Phoenixville, PA), Jain; Nemichand B. (Princeton Junction, NJ) |
Assignee: | Aprecia Pharmaceuticals Company (Langhorne, PA) |
Application Number: | 15/095,785 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 9,669,009
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-004 | Jul 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | METHOD OF ADMINISTERING LEVETIRACETAM UNDER FASTED CONDITIONS | Start Trial | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-004 | Jul 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | METHOD OF ADMINISTERING LEVETIRACETAM | Start Trial | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-004 | Jul 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | METHOD OF ADMINISTERING LEVETIRACETAM UNDER FED CONDITIONS | Start Trial | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-001 | Jul 31, 2015 | RX | Yes | No | Start Trial | Start Trial | METHOD OF ADMINISTERING LEVETIRACETAM UNDER FED CONDITIONS | Start Trial | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-001 | Jul 31, 2015 | RX | Yes | No | Start Trial | Start Trial | METHOD OF ADMINISTERING LEVETIRACETAM UNDER FASTED CONDITIONS | Start Trial | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-001 | Jul 31, 2015 | RX | Yes | No | Start Trial | Start Trial | METHOD OF ADMINISTERING LEVETIRACETAM | Start Trial | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-002 | Jul 31, 2015 | RX | Yes | No | Start Trial | Start Trial | METHOD OF ADMINISTERING LEVETIRACETAM UNDER FASTED CONDITIONS | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,669,009
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2014228990 | Start Trial | |||
Australia | 2017202752 | Start Trial | |||
Canada | 2906029 | Start Trial | |||
China | 105188849 | Start Trial | |||
China | 109908355 | Start Trial | |||
European Patent Office | 2968994 | Start Trial | |||
European Patent Office | 3431141 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |